Abstract
Aims: We aimed to evaluate the impact of delay from diagnostic pre-hospital electrocardiogram (ECG) to wiring of the infarct-related vessel (ECG-to-wire) >120 minutes on cardiovascular magnetic resonance (CMR) markers of reperfusion success and clinical outcome in patients with ST-segment elevation myocardial infarction (STEMI). Methods and results: We included 1,492 patients in the analyses of clinical outcome. CMR was performed in 748 patients to evaluate infarct size and myocardial salvage. In total, 304 patients (20%) had ECG-to-wire >120 minutes, which was associated with larger acute infarct size (18% [interquartile range (IQR), 10-28] vs. 15% [8-24]; p=0.022) and smaller myocardial salvage (0.42 [IQR 0.28-0.57] vs. 0.50 [IQR 0.34-0.70]; p=0.002). However, 33% of the patients with ECG-to-wire >120 minutes still had a substantial myocardial salvage ≥0.50. In a multivariable analysis, ECG-to-wire >120 minutes was associated with an increased risk of all-cause mortality and heart failure (hazard ratio 1.61, 95% confidence interval [CI] 1.14-2.26, p=0.007). Conclusions: ECG-to-wire >120 minutes was associated with larger infarct size, smaller myocardial salvage and a poorer clinical outcome in STEMI patients transferred for primary percutaneous coronary intervention. However, myocardial salvage was still substantial in one third of patients treated beyond 120 minutes of delay.
| Original language | English |
|---|---|
| Pages (from-to) | 700-707 |
| Number of pages | 8 |
| Journal | EuroIntervention |
| Volume | 14 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - Aug 2018 |
Funding
This work was supported by the Danish Agency for Science, Technology and Innovation, and the Danish Council for Strategic Research (Eastern Denmark Initiative to Improve Revascularization Strategies [EDITORS], grant 09-066994). J. Lønborg reports receiving fees from St. Jude Medical. L. Køber reports receiving grants from the Danish Research Foundation. T. Engstrøm reports receiving fees from St. Jude Medical, Bayer, Boston Scientific and AstraZeneca. The other authors have no conflicts of interest to declare.
Keywords
- Clinical research
- MRI
- Myocardial infarction
- STEMI
Fingerprint
Explore the research areas of 'Impact of diagnostic ECG-to-wire delay in STEMI patients treated with primary PCI: A DANAMI-3 substudy'.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver